NT5E and rheumatoid arthritis: Nonetheless, we cannot exclude that CD39 and CD73 expression are influenced by immunosuppressive medication as has been demonstrated for methotrexate in the treatment of rheumatoid arthritis patients40,41 or azathioprine in inflammatory bowel disease patients42,43.